Glen Eagle Advisors, LLC Viatris Inc Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,108 shares of VTRS stock, worth $14,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,108Holding current value
$14,603% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,087Shares Held
963MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.85 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.22 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$819 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$758 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$749 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $16B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...